forum

SUNPHARMA Share Price Discussion

Sun Pharmaceutical Industries Ltd.
Sector: Pharmaceuticals and health care
... Read more
SUNPHARMA Share Price *
396.7 +2.05 (0.52%)
* (quote may be delayed)

SUNPHARMA Discussion Forum


sunpharma 396
Like
reply
Reply
share
Share

buy 397 target 400/403
Like
reply
Reply
share
Share

Jefferies on sun pharma
Co announced launch of its dry eye treatment drug Cequa
Expect it to have $70m peak sales in 2yrs
Remain +ve on Sun's specialty biz
Our doc survey indicates $300m Ilumya peak sales
Buy, TP Rs 520, valuations at 16x FY21 PE (20% disc. to peers)
Like
reply
Reply
share
Share

CS On Sun Pharma
Neutral, TP Rs 450
Cautious Due To Forensic Audit On FY16-18 Financials, Litigation On Ranbaxy Pdts
Margins Can Be High If Cequa Gets A Good Volume Share
Cequa To Help Optimise Ophthalmic Portfolio Spends
Like
reply
Reply
share
Share

MS On Sun Pharma
OW, TP Rs 505
Cequa Adds On To Its In-market NDA Products Ilumya, Absorica, Bromsite
Cequa Is Third Product In Its Ophthalmic Portfolio
Estimate $40-60 m In Revenues For Cequa Over The Next Couple Of Months
Like
reply
Reply
share
Share
An evening walk down D-St: Indian market rises for 2nd day in a row
Among the secondary indices, BSE Midcap outperformed Sensex, rising 0.44 percent while Smallcap index underperformed, ending with a mild gain of 0.12 percent.
Moneycontrol
Like
reply
Reply
share
Share
Sun Pharma Q2 PAT seen up 12% YoY to Rs. 1,114.8 cr: Emkay
Net Sales are expected to increase by 15.2 percent Y-o-Y (down 4.6 percent Q-o-Q) to Rs. 7,988.9 crore, according to Emkay.
Moneycontrol
Like
reply
Reply
share
Share
Yogananda N Naidu in SUNPHARMA
BUY SUNPHARMA ABOVE ⬆️ 395 TGS 398 » 401 » 40...

SUNPHARMA MADE HIGH 400.50 WITH + 6050 ✅✅
Like
reply
Reply
share
Share
Yogananda N Naidu in SUNPHARMA
BUY SUNPHARMA ABOVE ⬆️ 395 TGS 398 » 401 » 40...

SUN PHARMA 398 WITH +3300 ✅
Like
reply
Reply
share
Share

BUY SUNPHARMA ABOVE ⬆️ 395 TGS 398 » 401 » 405 UPTO 410 SL 387
Like
reply
Reply
share
Share

FRIENDS SUNPHARMA NOW VERY STRONG SUPPORT NEAR 376 IF BREAK THEN MORE DOWNFALL TILL 360-345-320....
MENTION STRONG RESISTANCE NEAR 396 IF CROSS INTRADE 402-408-416 EASILY SEEN
NOTED SUPPORT AND RESISTANCE LEVELS FOR TRADING.....
STAY CONNECTED WITH HIDDEN GEM
Like
reply
Reply
share
Share

SUNPHARMA - chart - 393576
# SUNPHARMA OVERVIEW
sunpharma will target 380 and found resistance at 382
Like
reply
Reply (1)
share
Share
Latest replies
myname @myname
Oct 10 11:11 PM

YE FAKE SCREENSHOT POST KARTE HAIN .Ye commodity biz scam hai bhai log inki baat pe bilkul bhi trade mat karna in logon ko kuch bhi nhi aata . In logon ne mera 60000 RS chori kar lia ye log chor hai scammers hain . Agar apna paisa bachana hai to in scammers logon se door rehna .
Scalping trade in SUNPHARMA
As you requested again I post my chart which I...

High 389.80
1
reply
Reply
share
Share

SUNPHARMA - chart - 393088
As you requested again I post my chart which I posted morning 9.09am
RBR method
Like
reply
Reply
share
Share

SUNPHARMA - chart - 393086
As you requested again I post my chart which I posted morning 9.09am
RBR method
Like
reply
Reply
share
Share

SUNPHARMA - chart - 393075
Check the time we post this is called scalping target 3 to 7 mins enjoy the day
Like
reply
Reply
share
Share

SUNPHARMA - chart - 393059
Wait for another rocket - 391
Like
reply
Reply
share
Share

Like this ?????
Like
reply
Reply (1)
share
Share
Latest replies

SUNPHARMA - 393033
Scalping............

Watch scalping
Like
reply
Reply
share
Share

SUNPHARMA - chart - 392833
wait for correct entry and target with in 5 to 10 mins - scalping
Like
reply
Reply
share
Share

SUNPHARMA - chart - 392743

Like
reply
Reply
share
Share
Morgan Stanley bullish on these 2 pharma stocks which could give 32-47% return
Morgan Stanley also has overweight rating on Lupin with a target price at Rs 1,003, implying 47 percent potential upside from current levels as it believes the share price will rise in absolute terms over the next 30 days.
Moneycontrol
Like
reply
Reply
share
Share

"RISKY JACKPOT"
SUNPHARMA BUY ABOVE 386
SL 384.50
TARGET "OPEN"
Like
reply
Reply (1)
share
Share
Latest replies

NEW HIGH 388.35
(-1650/- RISK PER LOT)😍
RISK 1: 1.60 TIMES PROFIT❤️
2,600/- PROFIT TILL NOW👍
Indian pharma market sees growth of 11.5% in Q2FY20
The July-October period saw outbreaks of infectious diseases in many parts of the country, aiding the growth of anti-infective segment to 14 percent YoY in the second quarter, beating overall IPM growth.
Moneycontrol
Like
reply
Reply
share
Share
Indian pharma market registers growth of 11.5% in Q2FY20
The July-October period saw outbreaks of infectious diseases in many parts of the country, aiding the growth of anti-infective segment to 14 percent YoY in the second quarter, beating overall IPM growth.
Moneycontrol
Like
reply
Reply
share
Share

SUNPHARMA - 390113
Buy sunpharma 380.25 target 384.65-389.5-394.5 stoploss 378.65
Like
reply
Reply
share
Share
BCatchs in NIFTY-50
Pharma Index is now poised to re-enter the lag...

Pharma Index down by 2%. Sunpharma, Lupin could witness more weakness
Like
reply
Reply
share
Share

Sell SUNPHARMA TGT 381.35...(cmp 389.70)...
Like
reply
Reply
share
Share

Sun pharma buy 388/89
Like
reply
Reply
share
Share

SUNPHARMA - 383109
# SUNPHARMA OVERVIEW
Like
reply
Reply
share
Share

HARMONIC: ONCE BOOK AND EXIT SHORT IN SUNPHARMA OCT AT 387 AND LONG IN 410 CE @ 9.00. PROFIT RS 16170.
Like
reply
Reply
share
Share

buy subpharma near 393 sl 387.9
Like
reply
Reply
share
Share
An evening walk down D-St: Market falls for 2nd straight day; banks, financials top drag
Investors kept their bets low amid lack of fresh triggers at home and mixed global cues, while rupee's slide against the US dollar weighed on sentiment.
Moneycontrol
Like
reply
Reply
share
Share

Buy 400 ce 15 target 17 !19
Like
reply
Reply
share
Share

CS on Sun Pharma
Ilumya's success crucial given high opex
Already 1 yr since Ilumya launch & ramp-up still weak
Lower Ilumya est further for FY21 to $55m (from $80 m) & cut FY21E EPS to 19.6, now 15% lower than consensus We Cut TP to Rs 450 from Rs 470
Like
reply
Reply
share
Share

SUNPHARMA - chart - 378046
Sun Pharma
Like
reply
Reply
share
Share

*Sun Pharmaceutical Industries Limited:*
Shanghvi Finance Private Limied has bought 5,00,000 shares through Market Purchase on Sep 25, 2019.
1
reply
Reply
share
Share
Shardia in SUNPHARMA
sunpharma targets 411 and 414

411.5 First target hit
Like
reply
Reply
share
Share
Shardia in SUNPHARMA
buy sunpharma 408 -408.6 sl 406

sunpharma targets 411 and 414
Like
reply
Reply
share
Share
Shardia in SUNPHARMA
buy sunpharma 408 -408.6 sl 406

410.6 sl on cost now
Like
reply
Reply
share
Share

buy sunpharma 408 -408.6 sl 406
Like
reply
Reply
share
Share

Short sun pharma below 407 sl 411
Target 404/401/397/392
Like
reply
Reply
share
Share

Sell sunpharma 400 fast 390 second hit
Like
reply
Reply
share
Share

sell Sun Pharma below 403 , SL 410 Targets 400 , 385 ,
भारतीय निवेशक , विश्व बाजार तिन दिन तक लगातार गिरने वाला है।
#SellNifty #below11400 ,
SL11800 , #Target10500 for 3-5days
1
reply
Reply
share
Share
Corporate Tax Cut | Companies to gain Rs 44,000 crore from deferred tax liabilities: Report
Reliance Industries and ONGC are the biggest gainers as each stand to gain over Rs 13,000 crore because of deferred tax
Moneycontrol
Like
reply
Reply
share
Share

SUNPHARMA - 372979
Buy sunpharma 410.25 target 414.65-420-425-430 stoploss 408.55
1 st target done - happy trading
1
reply
Reply
share
Share

Stock Udpate: Some Risky Call:
SELL SUNPHARMA AT 413.50 WITH SL 417
TGT OPEN , jai ho!!!
Like
reply
Reply
share
Share

SUNPHARMA - 372556
Buy sunpharma 410.25 target 414.65-420-425-430 stoploss 408.55
Like
reply
Reply
share
Share
What should investors buy now? 25 Nifty50 stocks trading at a premium to their 10-yr average
Experts feel that the premium given to the stocks is justified, and will continue to dominate the space as they can be termed ‘safe bets’ in volatile times.
Moneycontrol
Like
reply
Reply
share
Share

Sun Pharma
Promoter group purchased 4,00,000 shares on 19 Sep from open market.
Like
reply
Reply
share
Share
  • SUNPHARMA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization114,986.45
    Enterprise Value120,496.68
    Price to EarningsNA
    Price to Book Value5.03
    Return on Capital Employed-0.01
    Return on Equity-0.03
    Face Value1
    Dividend YieldNA
  • SUNPHARMA Share Price - Technicals

    keyboard_arrow_down
    SUNPHARMA - 52 Week High₹616.8
    SUNPHARMA - 52 Week Low₹344.55
  • SUNPHARMA - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    16-Aug-19EdelweissReduce380
    14-Aug-19Karvy Stock BrokingHold462
    14-Aug-19Nirmal BangBuy578
    14-Aug-19Prabhudas LilladherReduce396
    14-Aug-19Reliance SecuritiesBuy500
    View all SUNPHARMA - Share Targets - Broker Reports
  • SUNPHARMA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Oct 14387399387394.65
    Oct 11387.4389.35381.5386.3
    Oct 10385389.8378.7387.05
    Oct 9378387.75374.2383.95
    Oct 7386.05387.65372.6379.9
  • SUNPHARMA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹401.68
    30 Day Moving Average₹411.11
    50 Day Moving Average₹415.31
    100 Day Moving Average₹410.12
    200 Day Moving Average₹426.4
  • SUNPHARMA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue7,9247,702.40.03
    Operating Profit-82795.27-9.68
    Profit Before Tax-520-32.4415.03
    Net Income-495-34.9513.16
  • SUNPHARMA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds22,84419,7700.16
    Total Liabilities14,87114,1540.05
    Total Assets37,71433,9240.11
  • SUNPHARMA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-1,184-1,623.95-0.27
    Cash from Investing Activity1,4062,383.85-0.41
    Cash from Financing Activity-272-752.98-0.64
    Net Cash Flow-506.92-8.23
  • SUNPHARMA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.01NA
    Return on Equity-0.03NA
    Return on Capital Employed-0.010.01
  • SUNPHARMA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.01
    3 Year CAGR Growth in Operating Profit-0.48
    3 Year CAGR Growth in EBIDTA1.86
    3 Year CAGR Growth in Net Income0.66
    3 Yr CAGR Growth - Diluted EPS0.71
  • SUNPHARMA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue2.26
    5 Year CAGR Growth in Operating Profit-2.61
    5 Year CAGR Growth in EBIDTA-0.6
    5 Year CAGR Growth in Net Income-1.96
    3 Yr CAGR Growth - Diluted EPS-1.41
  • SUNPHARMA Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Yesterday 10:33 PM
    An evening walk down D-St: Indian market rises for 2nd day in a row
    Moneycontrol
    NewsBot
    Yesterday 9:13 PM
    Sun Pharma Q2 PAT seen up 12% YoY to Rs. 1,114.8 cr: Emkay
    Moneycontrol
    NewsBot
    Oct 10 4:48 PM
    Morgan Stanley bullish on these 2 pharma stocks which could give 32-47% return
    Moneycontrol
    NewsBot
    Oct 10 1:38 AM
    Indian pharma market sees growth of 11.5% in Q2FY20
    Moneycontrol
    NewsBot
    Oct 9 11:08 PM
    Indian pharma market registers growth of 11.5% in Q2FY20
    Moneycontrol
    NewsBot
    Sep 30 10:33 PM
    An evening walk down D-St: Market falls for 2nd straight day; banks, financials top drag
    Moneycontrol
    NewsBot
    Sep 24 5:58 PM
    Corporate Tax Cut | Companies to gain Rs 44,000 crore from deferred tax liabilities: Report
    Moneycontrol
    NewsBot
    Sep 20 4:13 PM
    What should investors buy now? 25 Nifty50 stocks trading at a premium to their 10-yr average
    Moneycontrol
    NewsBot
    Sep 19 5:08 PM
    With 10% return likely in Nifty, CLSA likes these 10 largecaps
    Moneycontrol
    NewsBot
    Sep 18 10:48 PM
    An evening walk down D-St: Sensex, Nifty end higher ahead of US Fed rate decision
    Moneycontrol
  • SUNPHARMA - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.